Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Accumulated Expenses (2023 - 2025)

Jin Medical International's Accumulated Expenses history spans 3 years, with the latest figure at $388037.0 for Q3 2025.

  • For Q3 2025, Accumulated Expenses fell 9.97% year-over-year to $388037.0; the TTM value through Sep 2025 reached $388037.0, down 9.97%, while the annual FY2025 figure was $388037.0, 9.97% down from the prior year.
  • Accumulated Expenses for Q3 2025 was $388037.0 at Jin Medical International, down from $431003.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $431003.0 in Q3 2024 and bottomed at $318500.0 in Q3 2023.
  • The 3-year median for Accumulated Expenses is $388037.0 (2025), against an average of $379180.0.
  • The largest annual shift saw Accumulated Expenses skyrocketed 35.32% in 2024 before it decreased 9.97% in 2025.
  • A 3-year view of Accumulated Expenses shows it stood at $318500.0 in 2023, then surged by 35.32% to $431003.0 in 2024, then decreased by 9.97% to $388037.0 in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Accumulated Expenses are $388037.0 (Q3 2025), $431003.0 (Q3 2024), and $318500.0 (Q3 2023).